stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Guardant Health IncGH
$147.542.74%-4.16

Guardant Health Inc (GH)

Guardant Health Inc stock is traded at $147.54, with a volume of 123,204. It is down -2.74% in the last 24 hours and down -6.97% over the past month. Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Previous Close:
$151.70
Open:
$149.56
24h Volume:
123,204
Relative Volume:
0.04
Market Cap:
$19.96B
Revenue:
$1.08B
Net Income/Loss:
-$433.19M
P/E Ratio:
-
EPS:
-$3.40
Net Cash Flow:
-$225.09M
1W Performance:
-7.08%
1M Performance:
-6.97%
6M Performance:
+55.44%
1Y Performance:
+56.34%
1-Day Range:
$144.40$149.60
1-Week Range:
$144.40$163.39
52-Week Range:
$74.55$191.05

Guardant Health Inc Stock (GH) Company Profile

Name
Guardant Health Inc
Phone
855-698-8887
Address
3100 HANOVER STREET, PALO ALTO, USA
Employee
2,506
Next Earnings Date
-
Latest SEC Filings
SEC
GH's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Guardant Health Inc Stock (GH) Financials Data

Similar to GH